Carmat will equip a fourth patient with an artificial heart within three months at most, one of the company’s founders told BFM television on Wednesday.
The French company is conducting trials of its heart device that is designed as a permanent implant to extend the life of patients without them having to wait for a human heart donor.
Carmat’s first transplant patient, a 76-year-old man, died in March last year, two-and-a-half months after his operation.
Help employers find you! Check out all the jobs and post your resume.
